annual EBIT:
-$120.82M+$67.60M(+35.88%)Summary
- As of today (September 18, 2025), NVCR annual earnings before interest & taxes is -$120.82 million, with the most recent change of +$67.60 million (+35.88%) on December 31, 2024.
- During the last 3 years, NVCR annual EBIT has fallen by -$72.18 million (-148.42%).
- NVCR annual EBIT is now -438.58% below its all-time high of $35.68 million, reached on December 31, 2020.
Performance
NVCR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$39.52M-$1.66M(-4.37%)Summary
- As of today (September 18, 2025), NVCR quarterly earnings before interest & taxes is -$39.52 million, with the most recent change of -$1.66 million (-4.37%) on June 30, 2025.
- Over the past year, NVCR quarterly EBIT has dropped by -$5.91 million (-17.60%).
- NVCR quarterly EBIT is now -363.09% below its all-time high of $15.02 million, reached on September 30, 2020.
Performance
NVCR quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$171.83M-$5.91M(-3.56%)Summary
- As of today (September 18, 2025), NVCR TTM earnings before interest & taxes is -$171.83 million, with the most recent change of -$5.91 million (-3.56%) on June 30, 2025.
- Over the past year, NVCR TTM EBIT has increased by +$4.51 million (+2.56%).
- NVCR TTM EBIT is now -609.97% below its all-time high of $33.69 million, reached on March 31, 2021.
Performance
NVCR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NVCR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.9% | -17.6% | +2.6% |
| 3 y3 years | -148.4% | -87.1% | -218.9% |
| 5 y5 years | -2492.5% | -692.7% | -2455.7% |
NVCR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -148.4% | +35.9% | -87.1% | +36.9% | -218.9% | +24.0% |
| 5 y | 5-year | -438.6% | +35.9% | -363.1% | +36.9% | -610.0% | +24.0% |
| alltime | all time | -438.6% | +35.9% | -363.1% | +36.9% | -610.0% | +24.0% |
NVCR EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$39.52M(+4.4%) | -$171.83M(+3.6%) |
| Mar 2025 | - | -$37.87M(-39.3%) | -$165.91M(-1.0%) |
| Dec 2024 | -$120.82M(-35.9%) | -$62.35M(+94.3%) | -$167.54M(+11.6%) |
| Sep 2024 | - | -$32.09M(-4.5%) | -$150.19M(-14.8%) |
| Jun 2024 | - | -$33.61M(-14.9%) | -$176.34M(-14.1%) |
| Mar 2024 | - | -$39.49M(-12.3%) | -$205.40M(-9.2%) |
| Dec 2023 | -$188.42M(+140.0%) | -$45.00M(-22.7%) | -$226.16M(+0.9%) |
| Sep 2023 | - | -$58.24M(-7.0%) | -$224.13M(+17.7%) |
| Jun 2023 | - | -$62.66M(+4.0%) | -$190.50M(+27.9%) |
| Mar 2023 | - | -$60.25M(+40.2%) | -$148.97M(+66.4%) |
| Dec 2022 | -$78.51M(+61.4%) | -$42.98M(+74.6%) | -$89.52M(+28.0%) |
| Sep 2022 | - | -$24.61M(+16.5%) | -$69.94M(+29.8%) |
| Jun 2022 | - | -$21.13M(+2521.3%) | -$53.88M(+19.6%) |
| Mar 2022 | - | -$806.00K(-96.6%) | -$45.05M(+1.6%) |
| Dec 2021 | -$48.63M(-236.3%) | -$23.40M(+173.6%) | -$44.33M(+401.3%) |
| Sep 2021 | - | -$8.55M(-30.4%) | -$8.84M(-160.0%) |
| Jun 2021 | - | -$12.29M(>+9900.0%) | $14.73M(-56.3%) |
| Mar 2021 | - | -$88.00K(-100.7%) | $33.69M(+10.8%) |
| Dec 2020 | $35.68M(+606.6%) | $12.09M(-19.5%) | $30.40M(+64.7%) |
| Sep 2020 | - | $15.02M(+125.3%) | $18.46M(+153.1%) |
| Jun 2020 | - | $6.67M(-297.2%) | $7.29M(+300.3%) |
| Mar 2020 | - | -$3.38M(-2324.3%) | $1.82M(-299.1%) |
| Dec 2019 | $5.05M | $152.00K(-96.1%) | -$915.00K(-90.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $3.85M(+222.3%) | -$9.73M(-48.3%) |
| Jun 2019 | - | $1.20M(-119.5%) | -$18.83M(-30.5%) |
| Mar 2019 | - | -$6.12M(-29.4%) | -$27.11M(-19.5%) |
| Dec 2018 | -$29.67M(-22.4%) | -$8.66M(+65.2%) | -$33.67M(+14.1%) |
| Sep 2018 | - | -$5.25M(-26.0%) | -$29.51M(-2.2%) |
| Jun 2018 | - | -$7.08M(-44.1%) | -$30.19M(-21.9%) |
| Mar 2018 | - | -$12.68M(+181.3%) | -$38.63M(-1.8%) |
| Dec 2017 | -$38.24M(-66.9%) | -$4.51M(-23.9%) | -$39.33M(-25.4%) |
| Sep 2017 | - | -$5.92M(-61.9%) | -$52.70M(-29.8%) |
| Jun 2017 | - | -$15.53M(+16.1%) | -$75.05M(-16.9%) |
| Mar 2017 | - | -$13.37M(-25.2%) | -$90.34M(-17.0%) |
| Dec 2016 | -$115.53M(+10.3%) | -$17.88M(-36.8%) | -$108.91M(-10.5%) |
| Sep 2016 | - | -$28.27M(-8.3%) | -$121.63M(+3.4%) |
| Jun 2016 | - | -$30.82M(-3.5%) | -$117.60M(+3.2%) |
| Mar 2016 | - | -$31.94M(+4.4%) | -$113.98M(+9.6%) |
| Dec 2015 | -$104.77M(+30.5%) | -$30.60M(+26.3%) | -$103.96M(+41.7%) |
| Sep 2015 | - | -$24.24M(-10.9%) | -$73.36M(+49.3%) |
| Jun 2015 | - | -$27.20M(+24.1%) | -$49.12M(+13.8%) |
| Mar 2015 | - | -$21.91M(+3.2%) | -$43.15M(+10.0%) |
| Dec 2014 | -$80.26M(+14.9%) | - | - |
| Jun 2014 | - | -$21.23M(+17.9%) | -$39.24M(+117.9%) |
| Mar 2014 | - | -$18.01M | -$18.01M |
| Dec 2013 | -$69.86M | - | - |
FAQ
- What is NovoCure Limited annual earnings before interest & taxes?
- What is the all time high annual EBIT for NovoCure Limited?
- What is NovoCure Limited annual EBIT year-on-year change?
- What is NovoCure Limited quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NovoCure Limited?
- What is NovoCure Limited quarterly EBIT year-on-year change?
- What is NovoCure Limited TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NovoCure Limited?
- What is NovoCure Limited TTM EBIT year-on-year change?
What is NovoCure Limited annual earnings before interest & taxes?
The current annual EBIT of NVCR is -$120.82M
What is the all time high annual EBIT for NovoCure Limited?
NovoCure Limited all-time high annual earnings before interest & taxes is $35.68M
What is NovoCure Limited annual EBIT year-on-year change?
Over the past year, NVCR annual earnings before interest & taxes has changed by +$67.60M (+35.88%)
What is NovoCure Limited quarterly earnings before interest & taxes?
The current quarterly EBIT of NVCR is -$39.52M
What is the all time high quarterly EBIT for NovoCure Limited?
NovoCure Limited all-time high quarterly earnings before interest & taxes is $15.02M
What is NovoCure Limited quarterly EBIT year-on-year change?
Over the past year, NVCR quarterly earnings before interest & taxes has changed by -$5.91M (-17.60%)
What is NovoCure Limited TTM earnings before interest & taxes?
The current TTM EBIT of NVCR is -$171.83M
What is the all time high TTM EBIT for NovoCure Limited?
NovoCure Limited all-time high TTM earnings before interest & taxes is $33.69M
What is NovoCure Limited TTM EBIT year-on-year change?
Over the past year, NVCR TTM earnings before interest & taxes has changed by +$4.51M (+2.56%)